Urology Doctors in Harrison, AR Accepting Medicare

2 Urology doctors found. Showing 1 - 2

Dr. Scott Frazier Ferguson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 715 W Sherman Ave, Suite A, Harrison, AR 72601 Phone: 870-741-2317    Fax: 870-741-4090

Dr. Max Ann Ferguson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 715 W Sherman Ave, Suite A, Harrison, AR 72601 Phone: 870-741-2317    Fax: 870-741-4090

News Archive

Global effort needed to protect people from species-crossing diseases, Report finds

A team of health experts on Tuesday called for the U.S. "to lead a global effort to protect people from new outbreaks of deadly infectious diseases that originate in animals, such as swine flu, AIDS and SARS," Reuters writes (Morgan, 9/22).

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).

Urologix granted additional cure period to regain NASDAQ compliance

Urologix, Inc., announced today that it received a letter, dated February 16, 2011, from The NASDAQ Stock Market notifying Urologix that its request had been granted for an additional 180 calendar day cure period, until August 15, 2011, to regain compliance with the $1.00 per share minimum bid price requirement for continued listing on The NASDAQ Capital Market,

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide

Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.

Read more Medical News

› Verified 5 days ago